Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shujie Fan

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Frontiers in Pharmacology|August 20, 2024
Corrigendum: Proteasome inhibitor YSY01A abrogates constitutive STAT3 signaling via down-regulation of Gp130 and JAK2 in human A549 lung cancer cellsWei Huang, Xia Yuan, Ting Sun, et al.
Journal of Hematology & Oncology|June 6, 2022
DTX-P7, a peptide-drug conjugate, is highly effective for non-small cell lung cancerYao Jiang, Wei Huang, Xiaojiao Sun, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Frontiers in Pharmacology|August 20, 2024
Corrigendum: Proteasome inhibitor YSY01A abrogates constitutive STAT3 signaling via down-regulation of Gp130 and JAK2 in human A549 lung cancer cellsWei Huang, Xia Yuan, Ting Sun, et al.
Journal of Hematology & Oncology|June 6, 2022
DTX-P7, a peptide-drug conjugate, is highly effective for non-small cell lung cancerYao Jiang, Wei Huang, Xiaojiao Sun, et al.
Pageof 2